ProMIS Neurosciences
PMN
13 hedge funds and large institutions have $824K invested in ProMIS Neurosciences in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and closing their positions.
8% more funds holding
Funds holding: 12 → 13 (+1)
0.01% less ownership
Funds ownership: 0.1% → 0.09% (-0.01%)
27% less capital invested
Capital invested by funds: $1.13M → $824K (-$309K)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FT
Fiduciary Trust
Boston,
Massachusetts
|
+$56.8K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$6.01K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$17.5K |
| 2 |
JP Morgan Chase
New York
|
-$12K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$6.71K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.08K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NFC
1
Northeast Financial Consultants
Westport,
Connecticut
| $434K | – | – | – |
|
|
IC
2
IEQ Capital
Foster City,
California
| $170K | – | – | – |
|
|
3
Bank of America
Charlotte,
North Carolina
| $57.1K | -$6.71K | -48 | -8% |
|
|
CAM
4
Claret Asset Management
Montreal,
Quebec, Canada
| $55K | – | – | – |
|
|
FT
5
Fiduciary Trust
Boston,
Massachusetts
| $44.1K | +$56.8K | +406 | New |
|
|
6
JP Morgan Chase
New York
| $25K | -$12K | -86 | -28% |
|
|
7
Morgan Stanley
New York
| $12.2K | -$17.5K | -125 | -53% |
|
|
8
UBS Group
Zurich,
Switzerland
| $10.2K | -$3.08K | -22 | -19% |
|
|
9
Royal Bank of Canada
Toronto,
Ontario, Canada
| $10K | +$6.01K | +43 | +91% |
|
|
GCM
10
Gables Capital Management
Miami,
Florida
| $3.62K | – | – | – |
|
11
National Bank of Canada
Montreal,
Quebec, Canada
| $1.5K | – | – | – |
|
|
TWC
12
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $900 | – | – | – |
|
|
AWM
13
AllSquare Wealth Management
Albany,
New York
| $833 | – | – | – |
|
PMN Hedge Fund Activity: Q4 2022 in Review
13 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in ProMIS Neurosciences (PMN) for Q4 2022, worth a combined $824K — down 27% from $1.13M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PMN positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 4 trimmed.
The largest buyer was Fiduciary Trust, opening a new position worth an estimated $56.8K. The largest seller was Morgan Stanley, cutting an estimated $17.5K.
- 13 institutional investors held ProMIS Neurosciences (PMN) as of Q4 2022, up from 12 in Q3 2022.
- Funds reported $824K of ProMIS Neurosciences stock for Q4 2022, down 27% quarter-over-quarter.
- 1 fund opened new ProMIS Neurosciences positions in Q4 2022 and 0 closed out, a net change of +1 holder.
- The largest ProMIS Neurosciences buyer in Q4 2022 was Fiduciary Trust, an estimated $56.8K added.
- The largest ProMIS Neurosciences seller in Q4 2022 was Morgan Stanley, an estimated $17.5K sold.
Based on aggregated 13F filings for Q4 2022.